210 related articles for article (PubMed ID: 12374671)
1. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
[TBL] [Abstract][Full Text] [Related]
2. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
Awaya H; Takeshima Y; Amatya VJ; Ishida H; Yamasaki M; Kohno N; Inai K
Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H; Takeshima Y; Yamasaki M; Inai K
Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in atypical adenomatous hyperplasia of the lung.
Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
[TBL] [Abstract][Full Text] [Related]
7. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Herman JG
Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
[TBL] [Abstract][Full Text] [Related]
9. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
11. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
[TBL] [Abstract][Full Text] [Related]
13. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
14. STAT3 activation and aberrant ligand-dependent sonic hedgehog signaling in human pulmonary adenocarcinoma.
Yang Q; Shen SS; Zhou S; Ni J; Chen D; Wang G; Li Y
Exp Mol Pathol; 2012 Oct; 93(2):227-36. PubMed ID: 22554932
[TBL] [Abstract][Full Text] [Related]
15. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
16. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
[TBL] [Abstract][Full Text] [Related]
18. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
19. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
